Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
plenty of opportunities in the company for a dedicated employee who are capable and full of ideas
Was ist das Beste an Ihrem Vergütungspaket?
flexible working hours, comparable benefits in biotech
Was gefällt dir am besten am Führungsteam?
vision, hands-on, determined, quick decisions
Was sind einige der besten Dinge an Ihrem Team?
dedicated, learn quickly, collaborative style
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
innovative thinking, making impossible possible
Was macht Sie bei der Arbeit am glücklichsten?
challenges possibly meet every day opportunity to provide scientific suggestions and strategies which will make significant impact on the pipeline and company growth
Other Employee Reviews for Karyopharm Therapeutics
×